Protein

Recombinant Human Alkaline Phosphatase, Liver/Bone/Kidney (ALPL) Protein

  • Cat. No.:AP50062HU
  • Name:Recombinant Human Alkaline Phosphatase, Liver/Bone/Kidney (ALPL) Protein
Cat. No. Size Price


AP50062HU 100μg 380
AP50062HU 500μg 1140
PubMed Product Details
Technical Data

Species Reactivity

Human

Source

Prokaryotic expression

Host

E. coli

Synonyms

BALP; BSAP; HOPS; AP-TNAP; TNSALP; Bone Alkaline Phosphatase; Alkaline Phosphatase,Tissue-Nonspecific Isozyme

Concentration

1 mg/mL

Form

Lyophilized or Liquid

Purity

> 95% as determined by SDS-PAGE

Residues

N/A

Tag

N/A

Purification

Affinity purification

Molecular Weight(MW)

N/A

Applications

Western blotting,ELISA;SDS-PAGE;Antigen; Product Overview: Alkaline phosphatase, tissue-nonspecific isozyme is an enzyme encoded by the ALPL gene.There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2 while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. The exact physiological function of the alkaline phosphatases is not known. A proposed function of this form of the enzyme is matrix mineralization, however, mice that lack a functional form of this enzyme show normal skeletal development.
Usage: Reconstitute in PBS or others.
Stability: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Storage: Store it under sterile conditions at -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. Samples are stable for up to twelve months from date of receipt at -80℃.
Stroage Buffer: The protein solution is in 0.05M phosphate buffer containing 0.15M NaCl and 0.09% NaN3 pH 7.5. Filtered through a 0.25μM membrane
Precautions: This product is for research use only, not for diagnostic or therapeutic use.
Summary

Research topic

Bone and cartilage metabolism

Summary

Vitamin D is mainly synthesized in the skin from 7-dehydrocholesterol and is partially from dietary and supplementation origin. In the liver, Vitamin D is hydroxylated on carbon 25 to produce the intermediate 25OH Vitamin D. 25OH Vitamin D is further metabolized before it can carry out the functions of Vitamin D on intestine, kidneys, bone and other organs and tissues. This subsequent reaction takes place in the kidneys and in other tissues. Thus 25OH Vitamin D is further hydroxylated in the 1α-position to produce 1α,25-dihydroxyvitamin D (1,25(OH)2 Vitamin D). In addition to the above-mentioned tissues, placenta of pregnant women and macrophage cells in case of sarcoidis can also produce some amount of 1,25(OH)2 Vitamin D. 1,25(OH)2 Vitamin D is the active form of Vitamin D with regard to the known functions whereas 25OH Vitamin D and Vitamin D itself can be excluded as being physiologically functional. 1,25(OH)2 Vitamin D stimulates the intestinal absorption of both calcium and phosphorus. It also stimulates bone resorption and mineralization thereby preventing the development of rickets and osteomalacia. 1,25(OH)2 Vitamin D is also be active in other tissues responsible for Calcium transport (placenta, kidney, mammary gland,…) and endocrine glands such as parathyroid glands. 1,25(OH)2 Vitamin D is rapidly metabolized and its halflife is approximately 12h in plasma. Its main metabolite is calcitroic acid, a C-23 carboxylic derivative, essentially without any biological activity. In addition to this pathway, 1,25(OH)2 Vitamin D undergoes 24-hydroxylation to produce 1,24,25-trihydroxyvitamin D. This compound has less biological activity than its parent and this metabolic route is considered as a minor pathway. The levels of 1,25(OH)2 Vitamin D in plasma or serum is 100 to 1000 less than that of 25OH Vitamin D. Due to its low concentrations and the presence of many similar metabolites, the measurement of 1,25(OH)2 Vitamin D requires extraction and separation by chromatography.

Product References (1)

References

  • Parfieniuk-Kowerda A, Świderska M, Rogalska M, Maciaszek M, Jaroszewicz J,Flisiak R. Chronic hepatitis B virus infection is associated with decreased serum25(OH)D concentration in non-cirrhotic patients. Clin Exp Hepatol. 2019Mar;5(1):75-80. doi: 10.5114/ceh.2019.83160. Epub 2019 Feb 20. PubMed PMID:30915410; PubMed Central PMCID: PMC6431090. See more on PubMed
Summary References (1)

References to 1,25OH2 Vitamin D

  • Bouillon RA, Auwerx JH, Lissens WD, Pelemans WK. Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am J Clin Nutr. 1987 Apr;45 (4):755-63
Related Products Docs
COMPANY INTRODUCTION
——
Companies always with integrity, innovation, professional, service to win the trust of customers, we will abide by the integrity
management, intentions services, to create value for customers!

COMPANY INTRODUCTION
——
Full Contact Info
          xxx@.co.m
          020-000000 400-000000

Service case
——
HOME             FASHIONS             TREND               BRAND              JEANS